[Kidney involvement in light-chain deposition disease]

Area of Science:

• Nephrology
• Hematology
• Pathology

Background:

• Monoclonal gammopathy (MG) can lead to various kidney involvements.
• Light-chain deposition disease (LCDD) is a significant manifestation of MG, characterized by the deposition of light chains in tissues.

Observation:

• Renal lesions are common, serious, and well-documented complications of LCDD.
• A cohort of six patients diagnosed with LCDD via renal biopsy showed decreased renal function at diagnosis.
• One patient required hemodialysis treatment.

Findings:

• The pathophysiology of LCDD involves the deposition of immunoglobulin light chains or their stable domains.
• Monoclonal immunoglobulin overproduction, characteristic of MG, underlies LCDD.
• Clinical presentation of LCDD is multiorganic, with renal involvement being particularly prominent.

Implications:

• Therapeutic strategies for LCDD include symptomatic management of renal failure, corticosteroids, and cytostatic therapy.
• Despite treatment, the prognosis for most patients with LCDD remains guarded.
• Further research into novel therapeutic approaches for LCDD is warranted to improve patient outcomes.